As one of the earliest centers to carry out ROP screening and treatment in China, we reported the use of intravitreal injection of anti-VEGF agents or laser photocoagulation as first-line therapy among a total of 1,627 eyes of 862 premature infants from 2010 to 2018 in our center. This evidence concerns the gene VEGFA and retinopathy of prematurity.